Many researchers are currently investigating how to properly optimize nutrition to mitigate muscle loss while on triple agonists
Lancet Diabetes Endocrinol 6(4):275286 Rossing P, Baeres FMM, Bakris G, Bosch-Traberg H, Gislum M, Gough SCL et al (2023) The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
Zhu CG, Luo Y, Wang H, Li JY, Yang J, Liu YX, et al
It's a game-changer for reliable, all-day hunger control
Glucagon: Associated with increased energy expenditure and metabolic regulation, including the breakdown of stored energy
What Are Your Options Right Now (July 2026)